Biotechs do deal: Eviagenics divests flavonoid technology 02-Dec-2015 By Lynda Searby French biotech firm Alderys has bought Eviagenics’ micro-organism based flavonoid production platform for an undisclosed sum. The deal will allow Alderys to commercialise the technology and Eviagenics to focus on its seaweed extracts venture.